CTLA4 proteins and their uses
US9587007B2 · kind B2 · utility
5Cited by
17References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2014 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Nov 9, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.